APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalation General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalation General Anesthesia Drugs Market Outlook and Growth Opportunities 2026

Report ID 174002800427 December 2025192 pages

Choose your research edition.

Industry ResearchInhalation General Anesthesia Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation General Anesthesia Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Inhalation General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation General Anesthesia Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation General Anesthesia Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation General Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalation General Anesthesia Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalation General Anesthesia Drugs market include AbbVie, Baxter, LAB UNKNOWN, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris and Hengrui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation General Anesthesia Drugs Segment by Company

AbbVie

Baxter

LAB UNKNOWN

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Hengrui

Inhalation General Anesthesia Drugs Segment by Type

Isoflurane

Sevoflurane

Other

Inhalation General Anesthesia Drugs Segment by Application

Hospital

Clinic

Other

Inhalation General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhalation General Anesthesia Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalation General Anesthesia Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalation General Anesthesia Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalation General Anesthesia Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation General Anesthesia Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation General Anesthesia Drugs industry.

Chapter 3: Detailed analysis of Inhalation General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalation General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalation General Anesthesia Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalation General Anesthesia Drugs Industry Trends Table 2. Inhalation General Anesthesia Drugs Industry Drivers Table 3. Inhalation General Anesthesia Drugs Industry Opportunities and Challenges Table 4. Inhalation General Anesthesia Drugs Industry Restraints Table 5. Global Inhalation General Anesthesia Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalation General Anesthesia Drugs Revenue Share by Company (2021-2026) Table 7. Global Inhalation General Anesthesia Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhalation General Anesthesia Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Inhalation General Anesthesia Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhalation General Anesthesia Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalation General Anesthesia Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Inhalation General Anesthesia Drugs Company, Product Type & Application Table 13. Global Inhalation General Anesthesia Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Isoflurane Table 18. Significant Companies of Sevoflurane Table 19. Significant Companies of Other Table 20. Global Inhalation General Anesthesia Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhalation General Anesthesia Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Inhalation General Anesthesia Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Inhalation General Anesthesia Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Inhalation General Anesthesia Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Inhalation General Anesthesia Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhalation General Anesthesia Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhalation General Anesthesia Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhalation General Anesthesia Drugs Sales Value Share by Type (2021-2026) Table 29. Global Inhalation General Anesthesia Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Inhalation General Anesthesia Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Inhalation General Anesthesia Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Inhalation General Anesthesia Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Inhalation General Anesthesia Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Inhalation General Anesthesia Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Inhalation General Anesthesia Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Inhalation General Anesthesia Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Inhalation General Anesthesia Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Inhalation General Anesthesia Drugs Sales Value Share by Application (2021-2026) Table 42. Global Inhalation General Anesthesia Drugs Sales Value Share by Application (2027-2032) Table 43. Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 46. Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 48. Global Inhalation General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhalation General Anesthesia Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Inhalation General Anesthesia Drugs Sales Value Share by Region (2021-2026) Table 51. Global Inhalation General Anesthesia Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Inhalation General Anesthesia Drugs Sales Value Share by Region (2027-2032) Table 53. Global Inhalation General Anesthesia Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Inhalation General Anesthesia Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Inhalation General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Inhalation General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 59. Global Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Inhalation General Anesthesia Drugs Sales Market Share by Country (2027-2032) Table 61. Global Inhalation General Anesthesia Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Inhalation General Anesthesia Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Inhalation General Anesthesia Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Inhalation General Anesthesia Drugs Sales Value Market Share by Country (2027-2032) Table 65. AbbVie Company Information Table 66. AbbVie Business Overview Table 67. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. AbbVie Inhalation General Anesthesia Drugs Product Portfolio Table 69. AbbVie Recent Development Table 70. Baxter Company Information Table 71. Baxter Business Overview Table 72. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Baxter Inhalation General Anesthesia Drugs Product Portfolio Table 74. Baxter Recent Development Table 75. LAB UNKNOWN Company Information Table 76. LAB UNKNOWN Business Overview Table 77. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio Table 79. LAB UNKNOWN Recent Development Table 80. Maruishi Company Information Table 81. Maruishi Business Overview Table 82. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Maruishi Inhalation General Anesthesia Drugs Product Portfolio Table 84. Maruishi Recent Development Table 85. Piramal Company Information Table 86. Piramal Business Overview Table 87. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Piramal Inhalation General Anesthesia Drugs Product Portfolio Table 89. Piramal Recent Development Table 90. PT Novell Pharmaceutical Company Information Table 91. PT Novell Pharmaceutical Business Overview Table 92. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio Table 94. PT Novell Pharmaceutical Recent Development Table 95. Viatris Company Information Table 96. Viatris Business Overview Table 97. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Viatris Inhalation General Anesthesia Drugs Product Portfolio Table 99. Viatris Recent Development Table 100. Hengrui Company Information Table 101. Hengrui Business Overview Table 102. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hengrui Inhalation General Anesthesia Drugs Product Portfolio Table 104. Hengrui Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Inhalation General Anesthesia Drugs Distributors List Table 108. Inhalation General Anesthesia Drugs Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Inhalation General Anesthesia Drugs Product Image Figure 2. Global Inhalation General Anesthesia Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalation General Anesthesia Drugs Sales (2021-2032) & (K Units) Figure 5. Global Inhalation General Anesthesia Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhalation General Anesthesia Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Isoflurane Image Figure 10. Sevoflurane Image Figure 11. Other Image Figure 12. Global Inhalation General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Inhalation General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalation General Anesthesia Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Inhalation General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhalation General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalation General Anesthesia Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Inhalation General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Inhalation General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Inhalation General Anesthesia Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Inhalation General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Inhalation General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Inhalation General Anesthesia Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Inhalation General Anesthesia Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Inhalation General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Inhalation General Anesthesia Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Inhalation General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Inhalation General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Inhalation General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Inhalation General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Inhalation General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Inhalation General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Inhalation General Anesthesia Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Inhalation General Anesthesia Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • LAB UNKNOWN
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Inhalation General Anesthesia Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalation General Anesthesia Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalation General Anesthesia Drugs Market Dynamics
  1. 2.1 Inhalation General Anesthesia Drugs Industry Trends
  2. 2.2 Inhalation General Anesthesia Drugs Industry Drivers
  3. 2.3 Inhalation General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Inhalation General Anesthesia Drugs Industry Restraints
3 Inhalation General Anesthesia Drugs Market by Company
  1. 3.1 Global Inhalation General Anesthesia Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Inhalation General Anesthesia Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Inhalation General Anesthesia Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalation General Anesthesia Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Inhalation General Anesthesia Drugs Company Ranking (2024-2026)
  6. 3.6 Global Inhalation General Anesthesia Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalation General Anesthesia Drugs Company Product Type and Application
  8. 3.8 Global Inhalation General Anesthesia Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalation General Anesthesia Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalation General Anesthesia Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalation General Anesthesia Drugs Market by Type
  1. 4.1 Inhalation General Anesthesia Drugs Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Other
  5. 4.2 Global Inhalation General Anesthesia Drugs Sales Volume by Type
  6. 4.2.1 Global Inhalation General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation General Anesthesia Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhalation General Anesthesia Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhalation General Anesthesia Drugs Sales Value by Type
  10. 4.3.1 Global Inhalation General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation General Anesthesia Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhalation General Anesthesia Drugs Sales Value Share by Type (2021-2032)
5 Inhalation General Anesthesia Drugs Market by Application
  1. 5.1 Inhalation General Anesthesia Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Inhalation General Anesthesia Drugs Sales Volume by Application
  6. 5.2.1 Global Inhalation General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation General Anesthesia Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Inhalation General Anesthesia Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Inhalation General Anesthesia Drugs Sales Value by Application
  10. 5.3.1 Global Inhalation General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalation General Anesthesia Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Inhalation General Anesthesia Drugs Sales Value Share by Application (2021-2032)
6 Inhalation General Anesthesia Drugs Regional Sales and Value Analysis
  1. 6.1 Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation General Anesthesia Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032)
  5. 6.3 Global Inhalation General Anesthesia Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalation General Anesthesia Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalation General Anesthesia Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalation General Anesthesia Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalation General Anesthesia Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Inhalation General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalation General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalation General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Inhalation General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalation General Anesthesia Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalation General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
7 Inhalation General Anesthesia Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Inhalation General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalation General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalation General Anesthesia Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalation General Anesthesia Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalation General Anesthesia Drugs Sales by Country (2027-2032)
  6. 7.4 Global Inhalation General Anesthesia Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalation General Anesthesia Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalation General Anesthesia Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalation General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalation General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalation General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie
  2. 8.1.1 AbbVie Company Information
  3. 8.1.2 AbbVie Business Overview
  4. 8.1.3 AbbVie Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Inhalation General Anesthesia Drugs Product Portfolio
  6. 8.1.5 AbbVie Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Inhalation General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 LAB UNKNOWN
  14. 8.3.1 LAB UNKNOWN Company Information
  15. 8.3.2 LAB UNKNOWN Business Overview
  16. 8.3.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio
  18. 8.3.5 LAB UNKNOWN Recent Developments
  19. 8.4 Maruishi
  20. 8.4.1 Maruishi Company Information
  21. 8.4.2 Maruishi Business Overview
  22. 8.4.3 Maruishi Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Maruishi Inhalation General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Maruishi Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Inhalation General Anesthesia Drugs Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 PT Novell Pharmaceutical
  32. 8.6.1 PT Novell Pharmaceutical Company Information
  33. 8.6.2 PT Novell Pharmaceutical Business Overview
  34. 8.6.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio
  36. 8.6.5 PT Novell Pharmaceutical Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Inhalation General Anesthesia Drugs Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Hengrui
  44. 8.8.1 Hengrui Company Information
  45. 8.8.2 Hengrui Business Overview
  46. 8.8.3 Hengrui Inhalation General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hengrui Inhalation General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Hengrui Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 Inhalation General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation General Anesthesia Drugs Sales Mode & Process
  6. 9.2 Inhalation General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation General Anesthesia Drugs Distributors
  9. 9.2.3 Inhalation General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst